English  |  正體中文  |  简体中文  |  2823024  
???header.visitor??? :  30273168    ???header.onlineuser??? :  1157
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yang p c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 406-430 of 2713  (109 Page(s) Totally)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-24T00:33:35Z EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR Wu S.-G.; YAO-WEN KUO; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:38Z Severe community-acquired pneumonia due to Legionella pneumophila serogroup 6 CHUNG-YU CHEN; Chen K.-Y.; Hsueh P.-R.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:37Z Hemothorax in a Medical Intensive Care Unit: Incidence, Comorbidity and Prognostic Factors CHUNG-YU CHEN; Hsu C.-L.; Chang C.-H.; Chen K.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:36Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed CHUNG-YU CHEN; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:33Z Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer CHUNG-YU CHEN; Lin J.-W.; Huang J.-W.; Chen K.-Y.; Shih J.-Y.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:31Z Astrocyte-elevated gene-1 confers resistance to pemetrexed in non-small cell lung cancer by upregulating thymidylate synthase expression CHUNG-YU CHEN; Chen Y.-Y.; Chen J.J.W.; Chen K.-Y.; Ho C.-C.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-23T03:20:29Z Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; Chen K.-Y.; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; CHUNG-YU CHEN; Liang S.-K.; CHUNG-YU CHEN; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A.
臺大學術典藏 2021-08-23T02:42:25Z Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit Hsiue E.H.-C.; Lee P.-L.; YUNG-HSUAN CHEN; Wu T.-H.; Cheng C.-F.; Cheng K.-M.; Yang P.-C.; Chen H.-W.; Lin P.-Y.; Chiang D.-L.; Wu H.-D.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-08-20T08:00:40Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors BIN-CHI LIAO; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2021-08-18T07:39:07Z Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma Yang P.-C.; JHE-CYUAN GUO; Hsieh M.-S.; Lin C.-C.; Hsu C.-H.
臺大學術典藏 2021-08-16T08:36:23Z Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality during Severe Sepsis Chung K.-P.; Chang H.-T.; Lo S.-C.; Chang L.-Y.; Lin S.-Y.; ARISTINE CHENG; Huang Y.-T.; Chen C.-C.; Lee M.-R.; Chen Y.-J.; Hou H.-H.; Hsu C.-L.; Jerng J.-S.; Ho C.-C.; Huang M.-T.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-08-11T03:46:53Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏 2021-08-11T03:46:53Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment ZHONG-ZHE LIN; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.
臺大學術典藏 2021-08-11T03:46:51Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; ZHONG-ZHE LIN; Yu C.-J.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2021-08-03T01:43:09Z Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses Chang S.-Y;Huang K.-Y;Chao T.-L;Kao H.-C;Pang Y.-H;Lu L;Chiu C.-L;Huang H.-C;Cheng T.-J.R;Fang J.-M;Yang P.-C.; Chang S.-Y; JIM-MIN FANG et al.
臺大學術典藏 2021-07-22T06:25:01Z Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma CHIH-YANG HSIAO; Yang P.-C.; Li X.; Huang K.-W.
臺大學術典藏 2021-07-22T06:25:01Z Linear radiofrequency ablation using dual switching-control mode achieves rapid and bloodless liver resection, an experimental research CHIH-YANG HSIAO; Yang P.-C.; Huang K.-W.
臺大學術典藏 2021-07-20T03:15:44Z Recommendations for Medical Education in Taiwan TZONG-SHINN CHU; Weed H.G.; Yang P.-C.
臺大學術典藏 2021-07-13T06:04:40Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; Yu C.-J.; LEE JIH-HSIANG; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2021-07-13T06:04:37Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer LEE JIH-HSIANG; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏 2021-07-13T06:04:34Z Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; LEE JIH-HSIANG; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Yang P.-C.; Hsiung C.A.
臺大學術典藏 2021-07-13T06:04:32Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; LEE JIH-HSIANG; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2021-07-07T03:41:26Z Prevention of elastase-induced emphysema in placenta growth factor knock-out mice Cheng S.L.; Wang H.C.; Yu C.J.; Tsao P.N.; Carmeliet P.; SHIH-JUNG CHENG; Yang P.C.
臺大學術典藏 2021-07-06T09:26:29Z CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; SZE-KWAN LIN; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Eugene Chin Y.; Kuo M.-L.
臺大學術典藏 2021-07-06T09:26:24Z Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136) Chang C.-C.;Yang M.-H.;Lin B.-R.;Chen S.-T.;Pan S.-H.;Hsiao M.;Lai T.-C.;Sze-Kwan Lin;Jeng Y.-M.;Chu C.-Y.;Chen R.-H.;Yang P.-C.;Chin Y.E.;Kuo M.-L.; Chang C.-C.; Yang M.-H.; Lin B.-R.; Chen S.-T.; Pan S.-H.; Hsiao M.; Lai T.-C.; SZE-KWAN LIN; Jeng Y.-M.; Chu C.-Y.; Chen R.-H.; Yang P.-C.; Chin Y.E.; Kuo M.-L.

Showing items 406-430 of 2713  (109 Page(s) Totally)
<< < 12 13 14 15 16 17 18 19 20 21 > >>
View [10|25|50] records per page